Aeglea BioTherapeutics names new finance chief; shares rise

Spyre Therapeutics

05/09/2023 17:28

** Shares of drug developer Aeglea BioTherapeutics Inc
 AGLE.O  up 2.1% at $0.60
    ** Co appoints Scott Burrows as CFO
    ** Jonathan Alspaugh, co's current President and CFO,
expected to transition into a strategic advisory consulting role
through Dec 31, 2023
    ** Including sessions move, AGLE shares up 31.6% YTD
    

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))